Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-23-008432

Options or other derivatives

  • Chief Financial Officer acquired 85,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Trujillo Carlos Chief Financial Officer 2023-11-20 Grant or award · Stock Option (Right to Buy) +85,000 85,000 D
Loading xslF345X05/ownership.xml…